Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") and further to our intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Covidh Technologies Limited has officially been renamed iSERA Lifesciences Limited, with effect from April 10, 2026, following approval from the Registrar of Companies, Pune. The name change was first approved by the Board on March 10, 2026, and then by shareholders through a Special Resolution at an Extraordinary General Meeting on April 02, 2026. The company's Memorandum and Articles of Association have been updated to reflect the new name. The company was originally incorporated as Aarya Consultants Private Limited, and its CIN (L72200PN1993PLC252720), BSE Scrip Code (534920), and ISIN (INE899M01020) remain unchanged. The shift from 'Technologies' to 'Lifesciences' in the name suggests a potential strategic pivot or rebranding toward the life sciences or healthcare sector.
Shareholders and investors should note that this is a name change only and does not affect the rights, liabilities, or shareholding structure of stakeholders. The shift in branding from a technology-focused identity to a life sciences identity may signal a change in business direction, which investors should monitor through the company's future disclosures.